|
|
Epidemiology of Atrial Fibrillation and StrokeClinical Studies of New Oral AnticoagulantsPractice GuidelinesPreventionAdditional Online Resources for CliniciansOnline Resources for Patients
|
Epidemiology of Atrial Fibrillation and Stroke |
||
Publications |
||
|
|
Clinical epidemiology of atrial fibrillation and related cerebrovascular events in the United States. Neurologist. 2008;14:143-150. |
|
|
|
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology. 1978;28:973-978. |
|
Online resources |
||
|
|
Framingham Heart Study |
|
|
Epidemiology | Clinical Studies | Practice Guidelines | Prevention | Resources
for Clinicians | Resources for Patients |
||
Clinical Studies of New Oral Anticoagulants |
||
Apixaban publications |
||
|
|
Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial: design and rationale. Am Heart J. 2010;159:331-339. |
|
|
|
Apixaban in patients with atrial fibrillation. NEJM. 2011;364:806-817. |
|
|
|
Apixaban versus warfarin in patients with atrial fibrillation. NEJM. 2011;365:981-992. |
|
|
|
Apixaban with antiplatelet therapy after acute coronary syndrome. NEJM. 2011;365:699-708. |
|
|
|
Dual antiplatelet therapy or apixaban in patients ineligible for vitamin-K antagonists for stroke prevention in atrial fibrillation: lessons from the recent aspirin-controlled trials. J Am Coll Cardiol. 2011;57:E61. |
|
|
|
Effect of apixaban an oral direct and selective factor Xa inhibitor on inflammatory biomarkers following acute coronary syndrome. J Am Coll Cardiol. 2011;57:E1039. |
|
Dabigatran publications |
||
|
|
Anticoagulant options—why the FDA approved a higher but not a lower dose of dabigatran. NEJM. 2011;364:1788-1790. |
|
|
|
Cost analysis of substituting dabigatran for warfarin in an anticoagulation management service. J Am Coll Cardiol. 2011;57:E1188. |
|
|
|
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Ann Intern Med. 2011;154:1-11. |
|
|
|
Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation. Circulation. 2011;123:2562-2570. |
|
 |
Dabigatran challenges warfarin’s superiority for stroke prevention in atrial fibrillation. Stroke. 2010;41:1307-1309. |
|
|
|
Dabigatran etexilate versus warfarin in patients with different types of atrial fibrillation: a RE-LY® subgroup analysis. J Am Coll Cardiol. 2011;57:E62. |
|
|
|
Dabigatran versus warfarin and impact of CHAD2-VASC score on outcome in atrial fibrillation patients: a RE-LY subgroup analysis. J Am Coll Cardiol. 2011;57:E7. |
|
|
|
Dabigatran versus warfarin in atrial fibrillation patients with low, moderate and high CHADS2 score: a RE-LY subgroup analysis. J Am Coll Cardiol. 2010;55:A1,E2. |
|
|
|
Dabigatran versus warfarin in patients with atrial fibrillation. NEJM. 2009;361:1139-1151. |
|
|
|
Dabigatran versus warfarin in the treatment of acute venous thromboembolism. NEJM. 2009;361:2342-2352. |
|
|
|
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) trial. Circulation. 2011;123:2363-2372. |
|
Rivaroxaban publications |
||
|
|
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. NEJM. 2011;365:883-891. |
|
Editorials and reviews |
||
|
|
Can we rely on RE-LY? NEJM. 2009;361:1200-1202. |
|
|
|
A new era for anticoagulation in atrial fibrillation. NEJM. 2011. doi:10.1056/NEJMe1109748. |
|
|
|
The new oral anticoagulants. Blood. 2010;115:15-20. |
|
|
|
Therapeutic potential of oral factor Xa inhibitors. NEJM. 2010;363:2559-2561. |
|
Online resources |
||
|
|
Stroke Trials Registry—A database of ongoing and completed clinical trials |
|
|
Epidemiology | Clinical Studies | Practice Guidelines | Prevention | Resources
for Clinicians | Resources for Patients |
||
Practice Guidelines |
||
Publications |
||
|
|
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011;57:223-242. |
|
|
|
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011;57:1330-1337. |
|
|
|
AHA/ASA Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:227-276. |
|
|
|
Guidelines for the management of atrial fibrillation, the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Euro Heart J. 2010;31:2369-2429. doi:10.1093/eurheartj/ehq278. |
|
|
|
Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:517-584. |
|
|
|
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor based approach: The Euro Heart Survey on Atrial Fibrillation. Chest. 2010;137:263-272. doi:10.1378/chest.09-1584. |
|
|
|
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ. 2011;342:d124. |
|
Online resources |
||
|
|
ACCF/AHA pocket guideline: management of patients with atrial fibrillation |
|
|
|
Top eight differences among the AF guidelines: Canadian, European, and US |
|
|
Epidemiology | Clinical Studies | Practice Guidelines | Prevention | Resources
for Clinicians | Resources for Patients |
||
Prevention |
||
Publications |
||
|
|
Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort. Stroke. 2010;41:2731-2738. |
|
|
|
Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial. BMJ. 2011;342:d3653. |
|
|
|
Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke. 2009;40:235-240. |
|
|
|
Stroke risk and antithrombotic strategies in atrial fibrillation. Stroke. 2010;41:2705-2713. |
|
Online resources |
||
|
|
CHADS2 Calculator for Atrial Fibrillation Stroke Risk |
|
|
|
CHA2DS2-VASc Calculator for Atrial Fibrillation Stroke Risk |
|
|
|
Heart Rhythm Society Webinar on Stroke Prevention in Patients with Atrial Fibrillation |
|
|
Epidemiology | Clinical Studies | Practice Guidelines | Prevention | Resources
for Clinicians | Resources for Patients |
||
Additional Online Resources for Clinicians |
||
Continuing medical education |
||
|
|
ASHP Advantage—Atrial Fibrillation Webinars, CME and Podcasts |
|
|
|
Atrial Fibrillation in Primary Care (AFIP)—A Tool for Primary Care Physicians |
|
|
|
Cleveland Clinic Center for Continuing Education—Atrial Fibrillation |
|
|
|
Heart Rhythm Society—Atrial Fibrillation Awareness: Education for Healthcare Professionals |
|
|
|
Heart Rhythm Society—Atrial Fibrillation Webcasts |
|
|
|
PRESAGEcme™ Peer-to-Peer Podcast Series |
|
Patient education |
||
|
|
Atrial Fibrillation Patient Education Materials |
|
Other related websites |
||
|
|
American College of Physicians Foundation—Initiative on Atrial Fibrillation and Stroke Prevention |
|
|
|
Atrial Fibrillation—A CardioSource Clinical Community |
|
|
|
The Heart.org |
|
|
|
The Internet Stroke Center |
|
|
Epidemiology | Clinical Studies | Practice Guidelines | Prevention | Resources
for Clinicians | Resources for Patients |
||
Online Resources for Patients |
||
Learn more about atrial fibrillation and stroke |
||
|
|
National Stroke Association—Atrial Fibrillation |
|
|
|
American College of Cardiology CardioSmart™—Atrial Fibrillation |
|
|
|
American College of Physicians Foundation—Initiative on Atrial Fibrillation and Stroke Prevention |
|
|
|
American Heart Association—Atrial Fibrillation |
|
|
|
StopAfib.org—Atrial Fibrillation: For Patients by Patients |
|
|
|
Cleveland Clinic—What Is Atrial Fibrillation? |
|
|
|
Heart Rhythm Society—Atrial Fibrillation |
|
|
|
The Internet Stroke Center |
|
|
|
Mayo Clinic—Atrial Fibrillation |
|
|
|
National Institute of Neurological Disorders and Stroke |
|
Calculate your stroke risk |
||
|
|
National Stroke Association—Stroke Risk Scorecard |
|
|
|
University of California San Diego—Stroke Risk Calculator (If You Have Atrial Fibrillation and Are 55 or Older) |
|
Access online videos |
||
|
|
National Stroke Association: Beat Your OddsSM Educational Toolkit and Patient Video |
|
|
|
Heart Rhythm Society Public Service Announcement: A-Fib Feels Like |
|
|
|
Life After Stroke Video Series |
|
|
Epidemiology | Clinical Studies | Practice Guidelines | Prevention | Resources
for Clinicians | Resources for Patients |
||
The Managing Atrial Fibrillation to Prevent Stroke Resource Center is supported by educational grants from the following companies: Ortho-McNeil, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC and Bristol-Myers Squibb and Pfizer, Inc..
1-800-STROKES
1-800-787-6537
9707 E. Easter Lane, Suite B
Centennial, CO 80112
info@stroke.org
